Institution
Hiroshima University Hospital
Also known as: 広島大学病院
- 101running trials
- 46closed trials
- 8,767publications (OpenAlex)
Running trials
Recruiting
Recruiting
Not yet recruiting
Recruiting
A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Recruiting
Active, not recruiting
Recruiting
Pancreatic Cancer Screening Using the Enzeavour Assay in Japan
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Recruiting
Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Active, not recruiting
Recruiting
A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors
Active, not recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Showing 50 of 101.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer9 recruiting
- Childhood cancers4 recruiting
- Head and neck cancer4 recruiting
- Crohn's disease3 recruiting
- Fatty liver disease (MASLD/MASH)3 recruiting
- Metastatic breast cancer3 recruiting
- Epilepsy2 recruiting
- Liver cirrhosis2 recruiting
- Ovarian cancer2 recruiting
- Prostate cancer2 recruiting
- Sarcoma2 recruiting
- Ulcerative colitis2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- IgA nephropathy1 recruiting
- Lupus (SLE)1 recruiting
- Myasthenia gravis1 recruiting
- Pancreatic cancer1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)
Completed
Completed
Completed
Completed
An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Completed
Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease
Completed
Completed
Completed
Completed
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
Registry name variants (41)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Hiroshima University Hospital
Hiroshima, 734-8551
105 trials
Hiroshima University Hospital
Hiroshima, Hiroshima, 734-8551
3 trials
NCT07497087A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Contact: Boehringer Ingelheim
Contact: Boehringer Ingelheim
Contact: Boehringer Ingelheim
Hiroshima University hospital, Cardiovascular Medicine
Hiroshima, 734-8551
2 trials
Hiroshima University Hospital
Hiroshima-shi, Hiroshima, 734-8551
1 trial
Hiroshima University Hospital
Minamiku, 734-8551
1 trial
Hiroshima University Hospital
Minami-Ku, Hiroshima 734-8551
1 trial
Hiroshima University Hospital_Department of Gastro.&Metabo.
Hiroshima-shi, Hiroshima, 734-8551
1 trial
Hiroshima University Hospital - Dept of Rheumatology/Immunology
Hiroshima
1 trial
Hiroshima University Hospital, Hematology
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, Hiroshima 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, Hiroshima 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, Hiroshima 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, Hiroshima 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, Hiroshima 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, Hiroshima 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, Hiroshima 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, Hiroshima 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, Hiroshima 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, Hiroshima 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, Hiroshima 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital
Hiroshima, Hiroshima 734-8551
1 trial
Contact: AbbVie GK Clinical Trial Registration Desk
Hiroshima University Hospital
Hiroshima, Hiroshima 734-8551
1 trial
Hiroshima University Hospital (Site 0117)
Hiroshima, 7348551
1 trial
Hiroshima University Hospital (Site 0156)
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital (Site 0320)
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital (Site 0352)
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital (Site 0655)
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital (Site 0743)
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital (Site 0762)
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital (Site 0916)
Hiroshima, 734-8551
1 trial
NCT06136624Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Contact: Study Coordinator
Hiroshima University Hospital (Site 1019)
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital (Site 1109)
Hiroshima, 7348551
1 trial
Hiroshima University Hospital (Site 1165)
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital (Site 1215)
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital (Site 1512)
Hiroshima, 734-8551
1 trial
Contact: Study Coordinator
Hiroshima University Hospital (Site 2845)
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital (Site 3418)
Hiroshima, 734-8551
1 trial
Contact: Study Coordinator
Hiroshima University Hospital (Site 3804)
Hiroshima, 734-8551
1 trial
Hiroshima University Hospital-Site Number : 3920007
Hiroshima, Hiroshima 734-8551
1 trial
Contact: Shintaro Hirata
Conditions
Diseases this institution publishes on or runs trials for.
- Haemophilia8 works · 3 trials
- ANCA-associated vasculitis8 works · 1 trial
Institution data: ROR 038dg9e86 (CC0-1.0)Updated 15 Nov 2026